SciSparc SPRC
NASDAQ SPRC
$6.74 -0.12 (-1.75%)
At close: Aug 20, 2026 · 4:00 PM EDT

SciSparc (SPRC) Operating Leases (2019 - 2024)

SciSparc (SPRC) posted Operating Leases of $9000.0 for Q4 2024, down 65.38% sequentially from $26000.0 in Q2 2024, and down 62.5% YoY from $24000.0 in Q1 2024.

SciSparc (SPRC) Operating Leases (2019 - 2024) Analysis & Trends

SciSparc has reported Operating Leases for 5 years, with the latest figure at $9000.0 in Q4 2024.

  • Quarterly Operating Leases fell 62.5% year-over-year to $9000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $9000.0 (down 62.5% YoY) and the FY2024 annual result came in at $9000.0, down 62.5% from the prior year.
  • Operating Leases slipped to $9000.0 in Q4 2024 per SPRC's latest filing, from $26000.0 in the prior quarter.
  • Over five years, Operating Leases peaked at $27000.0 in Q4 2022 and troughed at $9000.0 in Q4 2024.
  • A 4-year average of $20800.0 and a median of $24000.0 in 2023 frame the typical range for Operating Leases.
  • The sharpest annual moves came in 2022 and 2024: Operating Leases soared 50.0% in 2022, then plunged 62.5% in 2024.
  • Over 4 years, Operating Leases stood at $18000.0 in 2021, then jumped by 50.0% to $27000.0 in 2022, then retreated by 11.11% to $24000.0 in 2023, then slumped by 62.5% to $9000.0 in 2024.
  • According to Business Quant data, Operating Leases over the past three periods registered $9000.0, $26000.0, and $24000.0 for Q4 2024, Q2 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn
10 SciSparc 836,385.99 836,385.99 -

Historic Data

Download Data
DateValue
Dec 31, 2024 9,000.00
Jun 30, 2024 26,000.00
Dec 31, 2023 24,000.00
Dec 31, 2022 27,000.00
Dec 31, 2021 18,000.00
Dec 31, 2019 94,000.00
Jun 30, 2019 116,000.00